Skip to content

AV Submits Formal Comments for Proposed Rule on Drug Rebate Program

The Centers for Medicare and Medicaid Services should increase transparency, improve regulatory definitions, and better ensure compliance.

This week Arnold Ventures submitted formal comments to the Centers for Medicare and Medicaid Services on a proposed rule to strengthen the Medicaid Drug Rebate Program.

In the comments Arnold Ventures called for increased transparency, improved regulatory definitions, and manufacturer pricing surveys to ensure compliance with regulations aimed at lowering drug prices in Medicaid and preserving taxpayer dollars.

Read the letter here.